Delivery Order SPE2DB22D1106-SPE2DB25FFEY7
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,049.61 for INGREZZA 60 mg capsules (30-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $4,049.61 delivery order to AmerisourceBergen Drug Corp for INGREZZA 60 mg capsules (30-count units) on June 2, 2025, with a completion date of June 24, 2025. This non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of INGREZZA 40 mg capsules (30-count packages) with a ceiling value of $7,352.24. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 6, 2025. This delivery...
- The Defense Logistics Agency awarded a $3,676.12 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of INGREZZA 40 mg capsules (30-count units). This is a firm fixed-price contract with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. INGREZZA is a pharmaceutical treatment used in military and...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 MG Capsule in a 30-count quantity under a firm fixed-price contract with a ceiling value of $3,676.12. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of June 24, 2025. AmerisourceBergen Drug Corp will perform this work from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INGREZZA 80 MG capsules (30-count supply) valued at $4,027.70 under a firm fixed price contract. The award was made on September 11, 2025, with an ultimate completion date of October 2, 2025. This is a non-set-aside competitive award executed as a delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of INGREZZA 80 MG capsules (30-count units) with a ceiling value of $8,055.40. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,049.61 to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of INGREZZA 60 mg capsules (30-count units). This is a firm fixed price delivery order with no set-aside designation, issued competitively under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies a completion date of June 17, 2025, and identifies AmerisourceBergen's Corporate Office in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,676.11 to AmerisourceBergen Drug Corp for INGREZZA 40 mg capsules (30-count units) on October 15, 2025, with an ultimate completion date of November 5, 2025. This firm fixed-price, competitively awarded contract (without set-aside designation) represents a purchase of pharmaceutical inventory to support federal medical supply requirements. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,676.12 to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 MG capsules (30-count units) under a firm fixed-price contract. The delivery order, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFEY7Delivery Order
The Defense Logistics Agency awarded a $11,028.36 delivery order to AmerisourceBergen Drug Corp for INGREZZA 40 MG capsules (30-count units) on August 25, 2025, with completion expected by September 16, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies globally to support military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capacity to deliver brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This particular delivery order for INGREZZA—a neurological treatment—exemplifies the company's role in fulfilling DLA's pharmaceutical supply requirements through its comprehensive prime vendor contract vehicle, which supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 8/25/25 |